Health Catalyst, Inc. — Director's Dealing 2020

Aug 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2020-08-24

Reporting Person: Burton Daniel D. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-24	Common Stock	M	98554.00	$15.84	Acquired	256054.00	Direct
2020-08-24	Common Stock	M	5465.00	$10.80	Acquired	261519.00	Direct
2020-08-24	Common Stock	M	20.00	$6.24	Acquired	261539.00	Direct
2020-08-24	Common Stock	S	1900.00	$32.00	Disposed	259639.00	Direct
2020-08-24	Common Stock	S	8301.00	$31.18	Disposed	251338.00	Direct
2020-08-24	Common Stock	S	93838.00	$30.24	Disposed	157500.00	Direct
2020-08-25	Common Stock	M	17013.00	$15.84	Acquired	174513.00	Direct
2020-08-25	Common Stock	S	6080.00	$30.34	Disposed	168433.00	Direct
2020-08-25	Common Stock	S	10933.00	$30.88	Disposed	157500.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-24	Stock Option (Right to Buy)	$15.84	M	98554.00	Disposed	2029-02-05	Common Stock (98554.00)	Direct
2020-08-24	Stock Option (Right to Buy)	$10.80	M	5465.00	Disposed	2028-09-27	Common Stock (5465.00)	Direct
2020-08-24	Stock Option (Right to Buy)	$6.24	M	20.00	Disposed	2024-06-12	Common Stock (20.00)	Direct
2020-08-25	Stock Option (Right to Buy)	$15.84	M	17013.00	Disposed	2029-02-05	Common Stock (17013.00)	Direct

Footnotes

F1: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1.

F2: Represents the weighted average sale price of the shares sold ranging from $31.94 to $32.02 per share, inclusive.

F3: Represents the weighted average sale price of the shares sold ranging from $30.94 to $31.86 per share, inclusive.

F4: Represents the weighted average sale price of the shares sold ranging from $29.94 to $30.93 per share, inclusive.

F5: Represents the weighted average sale price of the shares sold ranging from $29.64 to $30.63 per share, inclusive.

F6: Represents the weighted average sale price of the shares sold ranging from $30.64 to $31.21 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) though (6).

F7: 25% of the 299,748 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.

F8: 25% of the 747,223 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.

F9: 25% of the 76,465 shares underlying the options vested in an annual installment on May 13, 2015 and the remaining balance vested in equal monthly installments until the option vested in full on May 13, 2018.